There are no big problems, there are just a lot of little problems.

And they are easy to solve.

eMedicals Logo

Founded in 2020, eMedicals Healthtech operates at the intersection of life sciences and healthtech, developing a cutting-edge biochemical platform for novel therapeutics while also pioneering next generation AI solutions for Nutrition-Sensitive Diseases (NSDs), with a primary focus on Chronic Kidney Disease (CKD), Cardiovascular Disease (CVD), and Type 2 Diabetes (T2D).

Through our advanced R&D results, eMedicals secured funding in 2021 from prestigious research excellence programs supported by the German Federal Ministry of Education and Research and the Hessian Ministry of Science and Art.

In 2022, we further strengthened our position by securing equity investment from industry-expert angel investors and obtaining a substantial bank loan, underscoring the robust support for our innovative approach.

Winner of InnoHealth China

Our Platform kidi

Based on our holistic approach, our platform kidi offers a wide range of services for patients, clinicians, insurers and pharma within the ecosystem of Nutrition-Sensitive Diseases.

Providing Value for multiple stakeholders

Patients

kidi empowers patients to synergistically manage their diet, medication, treatments, and health data, helping to reduce medication use, shorten hospital stays, and delay the need for dialysis.

Clinicians

Our Clinical Decision Support System (CDSS) streamlines doctors' daily workflows and enhances the quality of therapy decisions through advanced medical visual analytics tools.

Insurers

Our products have the potential to generate significant cost savings by reducing medication, hospitalisation and dialysis.

Pharma

We aim to provide an innovative food-based drug delivery system that uses everyday foods to deliver active pharmaceutical ingredients, improving medication efficacy and patient adherence.